{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T17:40:10Z","timestamp":1727718010093},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,30]]},"DOI":"10.7759\/cureus.70538","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T16:59:49Z","timestamp":1727715589000},"source":"Crossref","is-referenced-by-count":0,"title":["Role of Cariprazine in Managing and Preventing Refractory Catatonia: A Case Study"],"prefix":"10.7759","author":[{"given":"Zana A","family":"Qasab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12979","article-title":"Cariprazine for acute mood episodes in bipolar disorder","volume":"22","author":"Roza TH","year":"2020","unstructured":"Roza TH, Santos Lopes SL, Passos IC. Cariprazine for acute mood episodes in bipolar disorder. Bipolar Disord. 2020, 22:759-60. 10.1111\/bdi.12979","journal-title":"Bipolar Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2023.03.009","article-title":"Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: a hypothesis based on data","volume":"72","author":"Fountoulakis KN","year":"2023","unstructured":"Fountoulakis KN, Ioannou M, Tohen M, Haarman BC, Zarate CA Jr. Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: a hypothesis based on data. Eur Neuropsychopharmacol. 2023, 72:30-9. 10.1016\/j.euroneuro.2023.03.009","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1986.tb51245.x","article-title":"Changes in gamma-aminobutyric acid biochemistry and seizure threshold","volume":"462","author":"Green AR","year":"1986","unstructured":"Green AR. Changes in gamma-aminobutyric acid biochemistry and seizure threshold. Ann N Y Acad Sci. 1986, 462:105-19. 10.1111\/j.1749-6632.1986.tb51245.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2013.06.003","article-title":"Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis","volume":"54","author":"Lin CC","year":"2013","unstructured":"Lin CC, Huang TL. Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis. Compr Psychiatry. 2013, 54:1210-4. 10.1016\/j.comppsych.2013.06.003","journal-title":"Compr Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0b013e3182887a1a","article-title":"Effective treatment of catatonia by combination of benzodiazepine and electroconvulsive therapy","volume":"29","author":"Unal A","year":"2013","unstructured":"Unal A, Bulbul F, Alpak G, Virit O, Copoglu US, Savas HA. Effective treatment of catatonia by combination of benzodiazepine and electroconvulsive therapy. J ECT. 2013, 29:206-9. 10.1097\/YCT.0b013e3182887a1a","journal-title":"J ECT"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ppc.12150","article-title":"Cariprazine for the treatment of bipolar disorder","volume":"53","author":"Findlay LJ","year":"2017","unstructured":"Findlay LJ, El-Mallakh PL, El-Mallakh RS. Cariprazine for the treatment of bipolar disorder. Perspect Psychiatr Care. 2017, 53:148-55. 10.1111\/ppc.12150","journal-title":"Perspect Psychiatr Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.769897","article-title":"Cariprazine in the treatment of bipolar disorder: within and beyond clinical trials","volume":"12","author":"Do A","year":"2021","unstructured":"Do A, Keramatian K, Schaffer A, Yatham L. Cariprazine in the treatment of bipolar disorder: within and beyond clinical trials. Front Psychiatry. 2021, 12:769897. 10.3389\/fpsyt.2021.769897","journal-title":"Front Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-013-0004-9","article-title":"Cariprazine in bipolar disorder: clinical efficacy, tolerability, and place in therapy","volume":"30","author":"Citrome L","year":"2013","unstructured":"Citrome L. Cariprazine in bipolar disorder: clinical efficacy, tolerability, and place in therapy. Adv Ther. 2013, 30:102-13. 10.1007\/s12325-013-0004-9","journal-title":"Adv Ther"},{"key":"ref9","article-title":"Emergence of catatonia during ECT","volume":"17","author":"Malur C; Francis A","year":"2001","unstructured":"Malur C; Francis A. Emergence of catatonia during ECT. J ECT. 2001, 17:201-4.","journal-title":"J ECT"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S231573","article-title":"Electroconvulsive therapy for patients with catatonia: current perspectives","volume":"16","author":"Lloyd JR","year":"2020","unstructured":"Lloyd JR, Silverman ER, Kugler JL, Cooper JJ. Electroconvulsive therapy for patients with catatonia: current perspectives. Neuropsychiatr Dis Treat. 2020, 16:2191-208. 10.2147\/NDT.S231573","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12348","article-title":"Catatonia in 26 patients with bipolar disorder: clinical features and response to electroconvulsive therapy","volume":"17","author":"Medda P","year":"2015","unstructured":"Medda P, Toni C, Luchini F, Giorgi Mariani M, Mauri M, Perugi G. Catatonia in 26 patients with bipolar disorder: clinical features and response to electroconvulsive therapy. Bipolar Disord. 2015, 17:892-901. 10.1111\/bdi.12348","journal-title":"Bipolar Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1996.tb09815.x","article-title":"Catatonia. II. Treatment with lorazepam and electroconvulsive therapy","volume":"93","author":"Bush G","year":"1996","unstructured":"Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996, 93:137-43. 10.1111\/j.1600-0447.1996.tb09815.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref13","article-title":"Cariprazine, a new type - dopamine D\u2083 receptor preferring - partial agonist atypical antipsychotic for the treatment of schizophrenia and the primary negative symptoms (Article in Hungarian)","volume":"21","author":"Laszlovszky I","year":"2019","unstructured":"Laszlovszky I, Kiss B, Barabassy A, Kapas M, Nemeth G. Cariprazine, a new type - dopamine D\u2083 receptor preferring - partial agonist atypical antipsychotic for the treatment of schizophrenia and the primary negative symptoms (Article in Hungarian). Neuropsychopharmacol Hung. 2019, 21:103-18.","journal-title":"Neuropsychopharmacol Hung"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2022-100760","article-title":"Bipolar depression: a review of treatment options","volume":"35","author":"Levenberg K","year":"2022","unstructured":"Levenberg K, Cordner ZA. Bipolar depression: a review of treatment options. Gen Psychiatr. 2022, 35:e100760. 10.1136\/gpsych-2022-100760","journal-title":"Gen Psychiatr"},{"key":"ref15","article-title":"Cariprazine to treat schizophrenia and bipolar disorder in adults","volume":"50","author":"Edinoff A","year":"2020","unstructured":"Edinoff A, Ruoff MT, Ghaffar YT, et al.. Cariprazine to treat schizophrenia and bipolar disorder in adults. Psychopharmacol Bull. 2020, 50:83-117.","journal-title":"Psychopharmacol Bull"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/300749-role-of-cariprazine-in-managing-and-preventing-refractory-catatonia-a-case-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T16:59:51Z","timestamp":1727715591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/300749-role-of-cariprazine-in-managing-and-preventing-refractory-catatonia-a-case-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.70538","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}